TFRC and chronic myelogenous leukemia, BCR-ABL1 positive: These data add to the importance of NK cells in controlling residual CML cells, which has been noted in several “stop TKI” trials, where their elevated number, maturation, and function, have been associated with a better chance of TFR [14–16].